Pfizer Inc (PFE)

$28.02 -0.28 (-0.99%)
Market Cap 161.30B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 9.37
Forward PE 9.60
Profit Margin 12.42%
Debt to Equity Ratio 0.74
Volume 31,174,400
Avg Vol 44,044,414
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 72%
Beta 0.34
Analysts Sell
Price Target $28.60

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
Lowkeyoptions
Lowkeyoptions Aug. 28 at 12:55 AM
$BHVN $PFE hmmm!! biohaven pfe Pfizer Inc. completed its acquisition of Biohaven Pharmaceutical Holding Company Ltd. on October 3, 2022, for approximately $11.6 billion in cash. [1, 2] Deal Terms Cash Payment: Biohaven shareholders received $148.50 per share in cash. New Biohaven Spin-off: Shareholders also received 0.5 of a share in a new separate company ("New Biohaven") that kept the non-CGRP pipeline compounds. Total Value: The cash portion of the transaction was valued at $11.6 billion. [1, 2] Key Products & Assets NURTEC® ODT (rimegepant): An innovative pill approved to treat and prevent migraines in adults. VYDURA®: The European Union trade name for rimegepant. CGRP Portfolio: A collection of calcitonin gene-related peptide receptor antagonists designed for neurological diseases. [1]
0 · Reply
JBS_84
JBS_84 Aug. 27 at 11:52 PM
$PFE Positive articles so institutions can get short at a high price. They've no doubt took their positions by now, and you will begin seeing the price pullback followed by negative articles. I've said it before when everyone's saying it's going to 50, You sell when everyone's saying it's going to 20 buy. Simple.
0 · Reply
KilroyPicks
KilroyPicks Aug. 27 at 9:37 PM
$MIST - Rome wasn't built in a day. This drug is a specialty drug with a specific and relatively small patient base less than 1% of the US population. Also, this is Milestone's first drug so they are building relationships from scratch from doctors to the formulary channels. This will take a little longer to build than a drug from say Pfizer & $PFE or J&J $JNJ or Bristol-Myer Squib $BMY , those companies already have the relationships in place.
2 · Reply
focafoca99
focafoca99 Aug. 27 at 8:55 PM
$PFE got FDA approval for its XFG-adapted COVID-19 vaccine for seniors and high-risk adults. https://www.rapidticker.com/news/pfe-pfizer-and-biontech-receive-us-e396bc
0 · Reply
Outcomes
Outcomes Aug. 27 at 8:55 PM
$IBRX $MRNA $PFE $JNJ ......'why did I choose this career path? I am seeing so much carnage. I beg you. I am seeing so much autoimmunity developing. I've seen 4 men trying to conceive, not one single functioning sperm.' mRNA BAD. 'It is beyond all reasonable doubt' mRNA causes 'Turbo-cancers. And now, mRNA for cancer treatment. THE ULTIMATE HYPOCRISY. PSS KNOWS. https://x.com/ImBreckWorsham/status/2092973899935858784?s=20 SAVE THE CHILDREN. 🙏
5 · Reply
goguryo2000
goguryo2000 Aug. 27 at 8:35 PM
$PFE Recent Pipeline and Regulatory Updates Lyme Disease Vaccine: The European Medicines Agency (EMA) validated the Marketing Authorization Application for Pfizer and Valneva's joint Lyme disease vaccine candidate. Prostate Cancer Review: The FDA granted Priority Review for Pfizer's Talzenna combined with Xtandi to treat metastatic prostate cancer. Bladder Cancer Approval: The FDA approved Padcev plus Keytruda for muscle-invasive bladder cancer. Vitiligo Results: Pfizer announced positive Phase 3 topline results for Litfulo in patients suffering from nonsegmental vitiligo. Financial and Market Position Guidance: Management raised the 2026 revenue guidance midpoint by $500 million following steady non-COVID revenue recovery. Dividends: The company declared its third-quarter 2026 dividend while balancing cost-cutting initiatives to offset declining pandemic-era product sales.
0 · Reply
goguryo2000
goguryo2000 Aug. 27 at 7:50 PM
$PFE Happy with 28. Looking forward for 30. Happy trading.
1 · Reply
NorthOfSouth
NorthOfSouth Aug. 27 at 6:55 PM
$PFE This super f'd up market really started April 2025 when a certain individual made false claims about tariffs and crashed the markets...then repealed them and markets shot up...who loaded up at that time? Been pumped (AI) incessantly since then...Q: is when (after the major short positions have been established) will the plug be pulled? I know that I want a chair when the music stops...
2 · Reply
FlowAnomaly
FlowAnomaly Aug. 27 at 4:55 PM
$RVMD calls printing $MRNA $PFE $VSTM
0 · Reply
Loudermilk64
Loudermilk64 Aug. 27 at 4:05 PM
$PFE Pulling back up higher on the 1 week.
0 · Reply
Latest News on PFE
US FDA approves updated COVID vaccines for 2026-27 season

Aug 27, 2026, 5:48 PM EDT - 9 hours ago

US FDA approves updated COVID vaccines for 2026-27 season

MRNA NVAX SNY BNTX

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

2026-08-27T20:35:15.000Z - 10 hours ago

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

BNTX

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

Aug 27, 2026, 4:30 PM EDT - 10 hours ago

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

BNTX

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

Aug 26, 2026, 12:48 PM EDT - 1 day ago

White House to announce new drug pricing deals with biotechs, Bloomberg News reports

AMGN LLY

Pfizer Stock (PFE) Is a Buy despite Declining Revenue

2026-08-24T12:18:00.000Z - 3 days ago

Pfizer Stock (PFE) Is a Buy despite Declining Revenue

Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

2026-08-19T14:35:12.000Z - 8 days ago

Pfizer (PFE) Stock Rallies 4% Thanks to Merck (MRK) and Moderna (MRNA)’s Cancer Trial Update

BNTX MRK MRNA

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

2026-08-16T13:55:21.000Z - 11 days ago

Pfizer, Valneva announce EMA validation for PF-07307405 MAA

VALN

Pfizer (PFE) CEO Buys $1 Million of Company Stock

2026-08-14T18:45:04.000Z - 13 days ago

Pfizer (PFE) CEO Buys $1 Million of Company Stock

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Aug 14, 2026, 1:45 PM EDT - 13 days ago

Pfizer CEO Caps Post-Earnings Insider Buying Spree With $1 Million Stock Purchase

Closed Pfizer biopharma facility in Everett gets a new lease on life

Aug 14, 2026, 11:46 AM EDT - 13 days ago

Closed Pfizer biopharma facility in Everett gets a new lease on life

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Aug 14, 2026, 11:11 AM EDT - 13 days ago

Pfizer is paying $44 million to settle a Chantix lawsuit. See who could get money

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

2026-08-14T13:47:35.000Z - 13 days ago

Valneva Stock (VALN) Soars Over 20% On Lyme Disease Vaccine Hopes

VALN

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

Aug 14, 2026, 1:00 AM EDT - 14 days ago

Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

VALN

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 23 days ago

Pfizer Earnings Call Transcript: Q2 2026

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 23 days ago

Pfizer Earnings release: Q2 2026

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 23 days ago

Pfizer Slides: Q2 2026

Pfizer Quarterly report: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 23 days ago

Pfizer Quarterly report: Q2 2026

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:24 AM EDT - 23 days ago

Pfizer Post Loss on Higher Revenue

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:13 AM EDT - 23 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

Aug 4, 2026, 7:12 AM EDT - 23 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Aug 4, 2026, 6:52 AM EDT - 23 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 4, 2026, 6:45 AM EDT - 23 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Jul 30, 2026, 7:48 AM EDT - 4 weeks ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 30, 2026, 6:45 AM EDT - 4 weeks ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

Jul 29, 2026, 4:30 PM EDT - 4 weeks ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:48 PM EDT - 5 weeks ago

Pfizer's prostate cancer drug combination gets US FDA priority review

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 22, 2026, 4:30 PM EDT - 5 weeks ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

Jul 21, 2026, 7:10 PM EDT - 5 weeks ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 16, 2026, 1:39 PM EDT - 6 weeks ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 10, 2026, 11:23 AM EDT - 6 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jul 6, 2026, 10:00 AM EDT - 7 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

Jun 29, 2026, 4:43 PM EDT - 2 months ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 29, 2026, 1:20 AM EDT - 2 months ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 3:52 PM EDT - 2 months ago

Pfizer Declares Third-Quarter 2026 Dividend

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 2:10 PM EDT - 2 months ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 24, 2026, 10:51 AM EDT - 2 months ago

Pfizer dismissed from US states' drug price-fixing lawsuit

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 12:10 PM EDT - 2 months ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 23, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:43 PM EDT - 2 months ago

Pfizer's experimental drug misses main goal of lung cancer trial

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 4:30 PM EDT - 2 months ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

Jun 22, 2026, 2:32 PM EDT - 2 months ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:52 AM EDT - 2 months ago

Pfizer CFO Dave Denton to step down, leave company in August

Pfizer Announces Chief Financial Officer Transition

Jun 18, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Chief Financial Officer Transition

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Pfizer Press release: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 10:00 AM EDT - 3 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

Jun 4, 2026, 6:40 AM EDT - 3 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 2:00 PM EDT - 3 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Jun 1, 2026, 10:00 AM EDT - 3 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 31, 2026, 8:00 AM EDT - 3 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 30, 2026, 8:00 AM EDT - 3 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 29, 2026, 8:00 AM EDT - 3 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 11:10 PM EDT - 3 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:19 PM EDT - 3 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

Lowkeyoptions
Lowkeyoptions Aug. 28 at 12:55 AM
$BHVN $PFE hmmm!! biohaven pfe Pfizer Inc. completed its acquisition of Biohaven Pharmaceutical Holding Company Ltd. on October 3, 2022, for approximately $11.6 billion in cash. [1, 2] Deal Terms Cash Payment: Biohaven shareholders received $148.50 per share in cash. New Biohaven Spin-off: Shareholders also received 0.5 of a share in a new separate company ("New Biohaven") that kept the non-CGRP pipeline compounds. Total Value: The cash portion of the transaction was valued at $11.6 billion. [1, 2] Key Products & Assets NURTEC® ODT (rimegepant): An innovative pill approved to treat and prevent migraines in adults. VYDURA®: The European Union trade name for rimegepant. CGRP Portfolio: A collection of calcitonin gene-related peptide receptor antagonists designed for neurological diseases. [1]
0 · Reply
JBS_84
JBS_84 Aug. 27 at 11:52 PM
$PFE Positive articles so institutions can get short at a high price. They've no doubt took their positions by now, and you will begin seeing the price pullback followed by negative articles. I've said it before when everyone's saying it's going to 50, You sell when everyone's saying it's going to 20 buy. Simple.
0 · Reply
KilroyPicks
KilroyPicks Aug. 27 at 9:37 PM
$MIST - Rome wasn't built in a day. This drug is a specialty drug with a specific and relatively small patient base less than 1% of the US population. Also, this is Milestone's first drug so they are building relationships from scratch from doctors to the formulary channels. This will take a little longer to build than a drug from say Pfizer & $PFE or J&J $JNJ or Bristol-Myer Squib $BMY , those companies already have the relationships in place.
2 · Reply
focafoca99
focafoca99 Aug. 27 at 8:55 PM
$PFE got FDA approval for its XFG-adapted COVID-19 vaccine for seniors and high-risk adults. https://www.rapidticker.com/news/pfe-pfizer-and-biontech-receive-us-e396bc
0 · Reply
Outcomes
Outcomes Aug. 27 at 8:55 PM
$IBRX $MRNA $PFE $JNJ ......'why did I choose this career path? I am seeing so much carnage. I beg you. I am seeing so much autoimmunity developing. I've seen 4 men trying to conceive, not one single functioning sperm.' mRNA BAD. 'It is beyond all reasonable doubt' mRNA causes 'Turbo-cancers. And now, mRNA for cancer treatment. THE ULTIMATE HYPOCRISY. PSS KNOWS. https://x.com/ImBreckWorsham/status/2092973899935858784?s=20 SAVE THE CHILDREN. 🙏
5 · Reply
goguryo2000
goguryo2000 Aug. 27 at 8:35 PM
$PFE Recent Pipeline and Regulatory Updates Lyme Disease Vaccine: The European Medicines Agency (EMA) validated the Marketing Authorization Application for Pfizer and Valneva's joint Lyme disease vaccine candidate. Prostate Cancer Review: The FDA granted Priority Review for Pfizer's Talzenna combined with Xtandi to treat metastatic prostate cancer. Bladder Cancer Approval: The FDA approved Padcev plus Keytruda for muscle-invasive bladder cancer. Vitiligo Results: Pfizer announced positive Phase 3 topline results for Litfulo in patients suffering from nonsegmental vitiligo. Financial and Market Position Guidance: Management raised the 2026 revenue guidance midpoint by $500 million following steady non-COVID revenue recovery. Dividends: The company declared its third-quarter 2026 dividend while balancing cost-cutting initiatives to offset declining pandemic-era product sales.
0 · Reply
goguryo2000
goguryo2000 Aug. 27 at 7:50 PM
$PFE Happy with 28. Looking forward for 30. Happy trading.
1 · Reply
NorthOfSouth
NorthOfSouth Aug. 27 at 6:55 PM
$PFE This super f'd up market really started April 2025 when a certain individual made false claims about tariffs and crashed the markets...then repealed them and markets shot up...who loaded up at that time? Been pumped (AI) incessantly since then...Q: is when (after the major short positions have been established) will the plug be pulled? I know that I want a chair when the music stops...
2 · Reply
FlowAnomaly
FlowAnomaly Aug. 27 at 4:55 PM
$RVMD calls printing $MRNA $PFE $VSTM
0 · Reply
Loudermilk64
Loudermilk64 Aug. 27 at 4:05 PM
$PFE Pulling back up higher on the 1 week.
0 · Reply
StUngarjr
StUngarjr Aug. 27 at 4:04 PM
$PFE l’m writing this from the hospital. I just woke up after a 22 year coma. I see the stocks at 28 which it was when I went in to the coma. Question, how many times have we split? I can’t see my brokerage account yet, but must’ve split like 10 times since? So I have 10,000 shares not 1000?
0 · Reply
marketlimit
marketlimit Aug. 27 at 3:07 PM
$PFE back to $21 we go…
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 27 at 2:53 PM
$PFE tried to sell puts at 0.30 and they got to 0.27 🫩
0 · Reply
INEEDMONEY87
INEEDMONEY87 Aug. 27 at 1:41 PM
$PFE had me nervous, i actually put a stop up for the first time in 6 months....
0 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 27 at 1:11 PM
$PFE do we suck again?
3 · Reply
NorthOfSouth
NorthOfSouth Aug. 27 at 1:07 PM
$PFE sell, hold, buy ...You have 3 choices
0 · Reply
Samishere
Samishere Aug. 27 at 1:02 PM
$PFE
2 · Reply
NRG8
NRG8 Aug. 27 at 12:56 PM
$BRK.A $WMT $LLY $XOM $PFE Do you know of a more undervalued company than BZUN which is profitable, growing and has low debt? BZUN share price is $2.9 and today the company has raised FY28 forecast EPS to $1.79
1 · Reply
JuggernautRaider
JuggernautRaider Aug. 27 at 10:34 AM
$NUVB sold my shares: investing elsewhere! Good luck and Godspeed 🏃‍♂️ $GSK $NVS $PFE 💊 Adios mis amigos. Vaya Con Dios! 🙏 📕
1 · Reply
Samishere
Samishere Aug. 27 at 2:32 AM
$PFE
2 · Reply
Micheal_Pothead
Micheal_Pothead Aug. 26 at 9:42 PM
$PFE market is back to pumping AI
1 · Reply
Jtlo
Jtlo Aug. 26 at 9:10 PM
$PFE tomorrow load up 27 stock
1 · Reply